EurekAlert! -
27 Apr 2014 06:00
(The Lancet) Physicians do not have sufficient information from clinical trials to understand the risks associated with the prescription of testosterone in older men, according to a comment in The Lancet Diabetes & Endocrinology, written by professor Stephanie Page, of the University of Washington and Harborview Medical Center, Seattle, USA.
Share this Article